Background Medications used to treat inflammatory bowel disease (IBD) have significantly
improved patient outcomes and delayed time to surgery. However, some of these therapies …

The rate of abdominal surgical interventions and associated postoperative complications in
inflammatory bowel disease (IBD) patients is still substantially high. There is an ongoing …

BACKGROUND: Patients with ulcerative colitis may require colectomy for severe disease
unresponsive or refractory to pharmacological therapy. Managing ulcerative colitis is …

Purpose The present study explored preoperative risk factors (predictors) of incisional
surgical site infection (I-SSI) in severe or intractable ulcerative colitis (UC). Methods This …

Purpose In the era of biological therapy of ulcerative colitis (UC), surgical treatment
frequently consists of colectomy, end ileostomy, and rectal stump closure before patients go …

Tumor necrosis factor-alpha inhibitor (TNFi) treatment is effective for ulcerative colitis (UC)
and Crohn's disease (CD). Although several meta-analyses have been performed to …

Background and Aims: Patients with ulcerative colitis are often treated with multiple
immunomodulative agents to achieve remission. In refractory disease, the next option is …

Background and aims: Biologic therapy has emerged as an effective modality amongst the
medical treatment options available for ulcerative colitis (UC). However, its impact on post …

Introduction: The comprehensive complication index (CCI), which weights all postoperative
complications according to severity and integrates them into a single formula, has been …

Introduction Cohort studies have recently initiated a paradigm shift in the field of
preoperative bowel preparation. Indeed, the adjunction of oral antibiotics (OAB) to …